1. NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Issue 12 (16th December 2021) Authors: Zhang, Si Min; Rehling, Daniel; Jemth, Ann-Sofie; Throup, Adam; Landázuri, Natalia; Almlöf, Ingrid; Göttmann, Mona; Valerie, Nicholas C.K.; Borhade, Sanjay R.; Wakchaure, Prasad; Page, Brent D.G.; Desroses, Matthieu; Homan, Evert J.; Scobie, Martin; Rudd, Sean G.; Berglund, Ulrika Warpman; Söderb... Journal: Cell chemical biology Issue: Volume 28:Issue 12(2021) Page Start: 1693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAMHD1 is a barrier to antimetabolite-based cancer therapies. (4th March 2017) Authors: Rudd, Sean G.; Schaller, Torsten; Herold, Nikolas Journal: Molecular & cellular oncology Issue: Volume 4:Number 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAMHD1 protects cancer cells from various nucleoside-based antimetabolites. Issue 11 (3rd June 2017) Authors: Herold, Nikolas; Rudd, Sean G.; Sanjiv, Kumar; Kutzner, Juliane; Bladh, Julia; Paulin, Cynthia B. J.; Helleday, Thomas; Henter, Jan-Inge; Schaller, Torsten Journal: Cell cycle Issue: Volume 16:Issue 11(2017) Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Targeting the DNA damage response and repair in cancer through nucleotide metabolism. Issue 21 (28th May 2022) Authors: Helleday, Thomas; Rudd, Sean G. Journal: Molecular oncology Issue: Volume 16:Issue 21(2022) Page Start: 3792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗